Thrombogenics Nv operates within the Commercial physical research sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Thrombogenics Nv with three other
miscellaneous service companies in Europe:
Circassia Pharmaceuticals PLC
of the United Kingdom
sales of £10.80 million [US$13.28 million]
of which 95%
(99.93 million Norwegian Kroner [US$12.26 million]
Pharming Group NV
based in the Netherlands
(10.83 million Euro [US$11.89 million]
During the year ended December of 2015, sales at
Thrombogenics Nv were 11.20 million Euro (US$12.29 million).
decrease of 18.7%
versus 2014, when the company's sales were 13.78 million Euro.